Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001213900-23-032516
Filing Date
2023-04-25
Accepted
2023-04-25 16:28:42
Documents
8
Period of Report
2023-06-07

Document Format Files

Seq Description Document Type Size
1 PROXY STATEMENT def14a0423_optimizerxcorp.htm DEF 14A 1339460
2 GRAPHIC tbarchart_001.jpg GRAPHIC 283036
3 GRAPHIC tbarchart_002.jpg GRAPHIC 317620
4 GRAPHIC timage_001.jpg GRAPHIC 205077
5 GRAPHIC timage_002.jpg GRAPHIC 396142
6 GRAPHIC toprx_logo.jpg GRAPHIC 46776
7 GRAPHIC tproxy_001.jpg GRAPHIC 1049246
8 GRAPHIC tproxy_002.jpg GRAPHIC 820247
  Complete submission text file 0001213900-23-032516.txt   5636497
Mailing Address 400 WATER ST., STE. 200 ROCHESTER MI 48307
Business Address 400 WATER ST., STE. 200 ROCHESTER MI 48307 248-651-6558
OptimizeRx Corp (Filer) CIK: 0001448431 (see all company filings)

EIN.: 261265381 | State of Incorp.: NV | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-38543 | Film No.: 23845242
SIC: 7389 Services-Business Services, NEC